
Axis ESG Integration Strategy Fund(G)-Direct Plan
+5.20%
5Y annualised
+5.20%
5Y annualised
-0.48% 1D
Expert Rating Locked 🔒
Subscribe to unlock the ratings
- Lorem ipsum dolor sit amet, consectetur adipiscing elit.
- Mattis eget etiam curabitur a cras malesuada pulvinar.
Buy, Hold or Sell?
Unlock our SEBI-RIA verdict on this fund.

NAV : 13 Nov 2026
₹22.80
Min. SIP amount
₹100
Fund size (AUM)
962 Cr
Expense ratio
1.33%
Launched on
12 Feb 2020
Lock-in period
N/A
Benchmark
Nifty 50
Fund Plan
Direct
NAV : 13 Nov 2026
₹22.80
Min. SIP amount
₹100
Fund size (AUM)
962 Cr
Expense ratio
1.33%
Launched on
12 Feb 2020
Lock-in period
N/A
Benchmark
Nifty 50
Fund Plan
Direct
SIP Calculator + Returns
Monthly investment
₹8,000
Stock Allocation
Fund Composition
Large Cap
47.57%
Mid Cap
15.35%
Small Cap
16.03%
Others
21.05%
Sector Allocation
Cash & Cash Equivalents And Net Assets
13.34%
Finance
13.15%
Healthcare
10.94%
Bank
10.57%
Crude Oil
8.36%
Power
6.70%
Capital Goods
5.44%
Diamond & Jewellery
5.07%
Others
26.25%
Minimum investments
Returns vs rankings
Exit load, stamp duty and tax
Exit load
Nil for 10% of investment and 1% for remaining investment on or before 12M, Nil after 12M
No exit load after holding period
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within less than 1 year, returns are taxed as per your Income Tax slab. If you redeem after more than 1 year, returns are taxed at 12.5%.
Fund management
Vishal Agarwal
Present
Krishnaa N
Present
Pratik Tibrewal
Present
Similar/Peer Fund Comparison
ICICI Pru Strategic Metal and Energy Equity FoF(G)-Direct Plan
Kotak Healthcare Fund(G)-Direct Plan
HDFC Pharma and Healthcare Fund(G)-Direct Plan
Mirae Asset Healthcare Fund(G)-Direct Plan
Edelweiss Recently Listed IPO Fund(G)-Direct Plan
SBI Automotive Opportunities Fund(G)-Direct Plan
WOC Pharma and Healthcare Fund(G)-Direct Plan
PGIM India Healthcare Fund(G)-Direct Plan
FAQs
B. Premium Advisory - Everything in Basic, plus dedicated 1:1 expert calls, deeper portfolio reviews, personalised reports, and priority support to help you make confident, well-guided investment decisions.
